Thessalus Capital Management is a specialized investment firm that focuses on U.S. healthcare/technology sectors with narrow and deep emphasis on pharmaceuticals, biotechnology, and molecular diagnostics. We systematically review subdivisions of the life science/technology sector with a global, research-heavy approach, and allocate investment in areas of greatest medium- and long-term growth potential. Thessalus has a data-driven, sector-focused approach to investing in the healthcare/tech markets. We invest primarily in life science companies where current healthcare and research data points to unrealized, unprecedented opportunity for a company’s rapid growth, enhanced operational capability, and competitiveness.
